Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 075384
Company: MYLAN TECHNOLOGIES
Company: MYLAN TECHNOLOGIES
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 12/01/2000 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/75348ltr.pdf |